High-Performance Liquid Chromatography (HPLC) Market

The global HPLC market is projected to reach USD 12.2 billion by 2031, up from USD 7.86 billion in 2026, at a 9.3% CAGR during 2026–2031. Demand is supported by pharmaceutical quality control, impurity profiling, stability testing, and food and environmental analysis. Key developments include faster UHPLC workflows, automated method development, more sensitive detectors, and specialized columns for complex biopharmaceutical molecules.

GLP-1 and peptide therapeutics are creating opportunities for advanced chromatographic separation and impurity characterization. Reflecting this trend, Waters introduced BioResolve Peptide and GTxResolve Lipid columns in June 2026 for separating closely related impurities in GLP-1 peptides, insulin, and lipid nanoparticles. Agilent announced its 1290 Infinity III Fluorescence Detector in May 2026, supporting sensitive trace analysis at UHPLC speeds. These developments illustrate innovation across both separation consumables and detection technologies.

To know about the assumptions considered for the study download the pdf brochure

Emerging research applications further demonstrate HPLC and UHPLC's versatility. Studies reported in 2026 include multi-toxin analysis in fish plasma, pharmaceutical stability assessment after spaceflight, and HPLC confirmation of pollutants extracted using microfluidic sample preparation. These applications expand the technology’s research potential, although broader validation is required before some become routine testing workflows.

Prominent HPLC manufacturers include Agilent Technologies, Bio-Rad Laboratories, Biotage, BUCHI Labortechnik, Cytiva, Gilson, Hamilton, Hitachi High-Tech, JASCO, Merck, Orochem Technologies, PerkinElmer, Phenomenex, Thermo Fisher Scientific, Waters Corporation, and Shimadzu Corporation, among others. Their portfolios encompass analytical systems and associated components, columns, and consumables.

Thermo Fisher Scientific Inc. (US): Thermo Fisher Scientific offers the Thermo Scientific Vanquish HPLC and UHPLC portfolio, including pumps, autosamplers, and multiple detector options. Its separation portfolio includes Accucore Vanquish columns, while associated consumables include vials, caps, tubing, and replacement parts. Chromeleon software supports instrument control and automated column and buffer scouting. Together, these offerings address routine quality control, analytical method development, and sensitive LC–MS workflows.

Waters Corporation (US): Waters supplies Alliance iS HPLC, Arc, and ACQUITY UPLC systems, alongside chromatography pumps, detectors, columns, and consumables. Its detector portfolio includes UV/visible, photodiode array, fluorescence, refractive index, and light-scattering technologies. The company’s 2026 introduction of specialized BioResolve Peptide and GTxResolve Lipid columns addresses demanding GLP-1 and lipid nanoparticle separations, highlighting opportunities for application-specific consumables in biopharmaceutical development and quality control.

Agilent Technologies, Inc. (US): Agilent offers the 1260 Infinity III and 1290 Infinity III LC systems, supported by pumps, detectors, InfinityLab Poroshell columns, and HPLC consumables. Its supplies include detector lamps, capillaries, valve rotor seals, fittings, and inline filters. The 2026 announcement of the 1290 Infinity III Fluorescence Detector demonstrates its focus on combining sensitive detection with fast UHPLC separations for demanding analytical workflows.

Related Reports:

High-Performance Liquid Chromatography (HPLC) Market by Product (System, Column, Detector, Pump, Consumables), Technology (Analytical, Preparative), End User (Pharma-biopharma, Academia, Clinical labs, F&B, Environmental, Forensics) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]